{"slug": "biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological", "title": "BioSync: Transformer-Based Cross-Modal Fusion for a Multimodal Physiological Digital Biomarker", "summary": "Researchers introduced BioSync, a transformer-based cross-modal fusion model that combines cardiac, neural, behavioral, and speech data into a continuous composite digital biomarker called the BioSync Index (BSI). In evaluations on synthetic cohorts, BioSync achieved an AUC of 0.928 in a cognitive-decline cohort and accuracy/F1 of 0.764/0.766 in a metabolic-autonomic cohort, outperforming standard feature concatenation (0.926 AUC and 0.756/0.758, respectively). The BSI correlated with latent severity (r=0.91 and r=0.68), but validation on real cohorts is still needed.", "body_md": "arXiv:2609.04504v1 Announce Type: new \nAbstract: Cardiac, neural, behavioral, and speech measurements from wearable and mobile devices provide partial, noise-sensitive views of physiological state. BioSync combines these measurements into the \\textbf{BioSync Index (BSI)}, a continuous composite digital biomarker defined under the BEST framework. The model applies multi-head self-attention to modality tokens and adds a linear branch whose hypothesis class includes standard feature concatenation. This architecture is motivated by latent-variable measurement theory and by the possibility that joint observations contain information unavailable from individual modalities. We evaluated BioSync on two literature-informed synthetic cohorts: a four-modality cognitive-decline cohort using HRV, EEG, actigraphy, and speech, and a metabolic-autonomic cohort structured around the public AI-READI wearable schema. In the cognitive cohort, BioSync and concatenation obtained AUCs of 0.928 and 0.926, respectively. In the metabolic cohort, BioSync obtained accuracy/F1 of 0.764/0.766, compared with 0.756/0.758 for concatenation. The BSI correlated with latent severity in both cohorts ($r=0.91$ and $r=0.68$). A pure-attention ablation obtained cognitive-cohort AUC 0.911, locating the increase to 0.928 in the combined wide-and-deep architecture. With matched modality-dropout training, BioSync led concatenation at five of six cognitive-cohort corruption rates and at the highest metabolic-cohort rate. Its cognitive-cohort AUC was also higher than five published digital-biomarker reference values, although differences in datasets and tasks preclude a controlled benchmark claim. Comparison with single-modality, early-fusion, and late-fusion designs across six prespecified criteria identifies the model's computational properties; validation on real cohorts remains necessary.", "url": "https://wpnews.pro/news/biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological", "canonical_source": "https://arxiv.org/abs/2609.04504", "published_at": "2026-09-07 04:00:00+00:00", "updated_at": "2026-09-07 04:28:36.047336+00:00", "lang": "en", "topics": ["artificial-intelligence", "machine-learning", "ai-research"], "entities": ["BioSync", "BioSync Index", "BEST framework", "AI-READI"], "alternates": {"html": "https://wpnews.pro/news/biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological", "markdown": "https://wpnews.pro/news/biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological.md", "text": "https://wpnews.pro/news/biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological.txt", "jsonld": "https://wpnews.pro/news/biosync-transformer-based-cross-modal-fusion-for-a-multimodal-physiological.jsonld"}}